ACR适宜性标准:胆道癌的分期与随访
本文为美国放射学会(ACR)关于胆道癌(胆囊癌及肝内、外胆管癌)分期与随访的适宜性标准。文件系统回顾文献,针对五个临床场景(胆囊癌局部区域分期、胆管癌局部区域分期、远处转移分期、治疗后评估、监测)给出影像检查推荐,强调增强CT和MRI是局部区域评估的主要手段,胸部、腹部和盆腔CT及FDG-PET用于远处分期和随访。
要点
- 增强CT和MRI是胆道癌局部区域分期的主要影像方法。
- 胸部、腹部和盆腔CT及FDG-PET用于远处转移分期和随访。
- 准确分期决定可切除与不可切除患者的治疗分流。
核心结论
- 增强CT和MRI是胆道癌局部区域评估的主要手段,胸部、腹部和盆腔CT及FDG-PET用于远处分期和随访。
研究设计与样本
- 由美国放射学会(ACR)多学科专家小组制定,基于对同行评议文献的系统分析,采用GRADE等方法学原则评估证据,并使用RAND/UCLA适宜性方法确定影像和治疗的适宜性。
临床应用与阅片要点
- 局部区域分期首选增强腹部CT或MRI,远处分期和随访应包含胸部、腹部和盆腔CT及FDG-PET。
- 文献缺乏或不明确时,专家意见可作为推荐的主要证据来源。
局限性
- 在同行评议文献缺乏或结论不明确的情况下,推荐可能主要依赖专家意见。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Biliary tract cancers, comprising gallbladder cancer and intrahepatic and extrahepatic cholangiocarcinoma, are uncommon but aggressive malignancies that are often diagnosed at an advanced stage. Accurate staging is critical because patients with localized disease may be candidates for curative resection, whereas those with unresectable or metastatic disease are triaged to systemic and palliative therapy. This document reviews the evidence for imaging in five clinical scenarios: locoregional staging of gallbladder cancer, locoregional staging of cholangiocarcinoma, staging of distant metastatic disease, posttreatment evaluation, and surveillance. Contrast-enhanced CT and MRI of the abdomen are the mainstays of locoregional assessment, whereas CT of the chest, abdomen, and pelvis and FDG-PET are used for distant staging and follow-up. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision process support the systematic analysis of the medical literature from peer reviewed journals. Established methodology principles such as Grading of Recommendations Assessment, Development, and Evaluation or GRADE are adapted to evaluate the evidence. The RAND/UCLA Appropriateness Method User Manual provides the methodology to determine the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where peer reviewed literature is lacking or equivocal, experts may be the primary evidentiary source available to formulate a recommendation.
引用
- Kamal O, Fung A, Vij A, et al. ACR Appropriateness Criteria® Staging and Follow-Up of Biliary Cancer. J Am Coll Radiol. 2026. PMID: 42955037. doi:10.1016/j.jacr.2026.09.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。